Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma
- PMID: 16490513
- DOI: 10.1016/j.ajo.2005.09.034
Topical ibopamine in the treatment of chronic ocular hypotony attributable to vitreoretinal surgery, uveitis, or penetrating trauma
Abstract
Purpose: To study whether topical ibopamine effectively increases the intraocular pressure in patients with ocular hypotony after vitreoretinal surgery, uveitis, or penetrating trauma.
Design: A prospective randomized, double-blind, placebo controlled, crossover study.
Methods: In ten patients with ocular hypotony, an ibopamine 2% solution or placebo eyedrop was administered at 8 am and frequent applanation tonometry was performed during 10 hours on 2 days, 2 weeks apart.
Results: The mean IOP integral after administration of ibopamine was 2.4 mm Hg higher (95% CI for median difference in AUC over 480 minutes [P = .010]) compared with placebo.
Conclusions: The results of the study show that an ibopamine 2% eyedrop twice a day may increase the IOP for a period of over 8 hours in patients with hypotony.
Similar articles
-
Six months treatment with ibopamine in patients with hypotony after vitreoretinal surgery for retinal detachment, uveitis or penetrating trauma.Retina. 2012 Apr;32(4):742-7. doi: 10.1097/IAE.0b013e3182265177. Retina. 2012. PMID: 21909052
-
[Treatment of uveitis-associated refractory ocular hypotony with topical ibopamine].Klin Monbl Augenheilkd. 2006 May;223(5):422-4. doi: 10.1055/s-2006-926574. Klin Monbl Augenheilkd. 2006. PMID: 16705521 German.
-
Ibopamine treatment in chronic hypotony secondary to long-lasting uveitis. A case report.Eur J Ophthalmol. 2000 Oct-Dec;10(4):332-4. doi: 10.1177/112067210001000411. Eur J Ophthalmol. 2000. PMID: 11192843
-
Ocular hypotony: a review.Compr Ophthalmol Update. 2007 Jan-Feb;8(1):29-37. Compr Ophthalmol Update. 2007. PMID: 17394757 Review.
-
Appraisal and management of ocular hypotony and glaucoma associated with uveitis.Int Ophthalmol Clin. 2000 Spring;40(2):175-203. doi: 10.1097/00004397-200004000-00014. Int Ophthalmol Clin. 2000. PMID: 10791265 Review. No abstract available.
Cited by
-
Keratoprosthesis, silicone oil placement, and fluocinolone acetonide implant for treatment of uveitis-associated hypotony and keratopathy.J Ophthalmic Inflamm Infect. 2022 Feb 4;12(1):5. doi: 10.1186/s12348-022-00284-4. J Ophthalmic Inflamm Infect. 2022. PMID: 35119525 Free PMC article.
-
Hypotony in patients with uveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.Ocul Immunol Inflamm. 2012 Apr;20(2):104-12. doi: 10.3109/09273948.2011.647228. Ocul Immunol Inflamm. 2012. PMID: 22409563 Free PMC article. Clinical Trial.
-
Treating uveitis-associated hypotony with pars plana vitrectomy and silicone oil injection.Retina. 2010 Jan;30(1):140-5. doi: 10.1097/IAE.0b013e3181b32f06. Retina. 2010. PMID: 19823108 Free PMC article.
-
Perfluoro-n-octane as a temporary intraocular tamponade in a staged approach to manage complex retinal detachments.Clin Ophthalmol. 2015 Feb 27;9:413-8. doi: 10.2147/OPTH.S76947. eCollection 2015. Clin Ophthalmol. 2015. PMID: 25784785 Free PMC article.
-
Ocular hypertension after EyeCee One preload lens implantation: a retrospective cohort study.Front Med (Lausanne). 2024 Jul 23;11:1402606. doi: 10.3389/fmed.2024.1402606. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39109227 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
